Correlates of nutritional status in Japanese centenarians

Facts, Research and Intervention in Geriatrics

Volumn 2000, Issue , 2000, Pages 61-76

  Hirose, Nobuyoshi ^a   Suzuki, M ^b   Arai, Y ^b   Nakazawa, S ^b  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2242464967     PISSN: 12824038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Vaupel JW, Carey JR, Christensen K, Johnson TE, Yashin AI, Holm NV. et al: Biodemographic trajectories of longevity. Science 1998; 280: 855-860.
2. Rowe JW, Kahn RL: Human aging: usual and successful. Science 1987; 237: 143-149.
3. Denke M, Wilson JD: Protein and energy malnutrition. In Harrison's Principles of Internal Medicine 14th edition, Fauci AS, Braunwald E, Isselbacher KJ, et al (eds.), McGraw-Hill New York, 1998, pp 452-454.
4. Bray GA: obesity. In Harrison's Principles of Internal Medicine 14th edition, Fauci AS, Braunwald E, Isselbacher KJ, et al (eds.), McGraw-Hill New York, 1998, pp 454-462.
5. Wick G, Grubeck-Loebenstein B: Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease. Immunological reviews 1997; 160: 171-184.
6. Corti MC, Guralink JM, Salive ME, Sorkin JD: Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994; 272: 1036-1042.
7. Sohal R S, Weindruck R: Oxidative stress, caloric restriction and aging. Science 1996; 273: 59-62.
8. Chan Y C, Suzuki M, Yamamoto S : Dietary, anthropometric, hematological and biochemical assessments of the nutritional status of centenarians and elderly people in Okinawa, Japan. J Am Coll Nutr 1997; 16: 229-35.
9. Takeda S, Noji H, Hirose N, et al: Nutritional intake by the oldest elderly Japanese-Tokyo centenarian study 6-. Nippon Ronen Igakkai Zasshi. 1998; 35: 548-556.
10. Chan Y C, Suzuki M et al: Nutritional status of centenarians assessed by active and anthropometric, hematological and biochemical characteristics. J Nutr Sci Vitaminol 1996; 42: 241-248.
11. Suzuki M, Kurahashi : Medicobiological studies on centenarians in Okinawa, measuring plasma lipid peroxide, proline, and plasma and intracellular tocopherol. In: Recent Advances in Aging Science Beregi E et al. eds., Monduzzi Editore, Bologna 1993, pp 1505.
12. Hirose N, Arai Y, Kawamura M et al: Nutritional parameters and nutritional status of centenarians. Nippon Ronen Igakkai Zasshi. 1997; 34: 324-330.
13. Scouba WW: Cytokine control of nutrition and metabolism in critical illness. Curr Probl Surg 1994; 31: 576-643.
14. Erschler WB: Interleukin-6: A cytokine for gerontologist J Am Geriatr Soc 1993; 41: 176-181.
15. Chiari MM, Bagnoli R, De Luca P et al: Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc. 1995; 43: 767-771.
16. Gabay C, Kushner I: Acute phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340: 448-454.
17. Franceschi C, Monti D, Barbieri D, Salvioli S, Grassilli E, Capri M et al: Successful immunosenescence and the remodeling of immune responses with aging. Nephrol Dial Transplant 1996; 11(supple 9): 18-25.
18. Paolisso G, Gambardella A, Balbi V, Ammendola S, D'Amore A, Varrichio M: Body composition, body fat distribution, and resting metabolic rate in healthy centenarians. Am J Clin Nutr 1995; 62: 746-750.
19. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD: Hypercoagulability in centenarians: The paradox of successful aging. Blood 1995; 85: 3144-3149.
20. Homma A, Shimonaka J, Nakazato K: Psychosomatic function in centenarians. Nippon Ronen Igakkai Zasshi. 1992; 29: 922-930.
21. Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987; 76: 4654-4679.
22. Resnick NM: Geriatric Medicine In Harrison's Principles of Internal Medicine 14th edition, Fauci AS, Braunwald E, Isselbacher KJ, et al (eds.), McGraw-Hill New York, 1998, pp 37-46.
23. Ross R: Mechanisms of Disease: Atherosclerosis-An inflammatory disease. N Engl J Med. 1999; 340: 115-126.
24. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.: Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336; 973-979.
25. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink GJ, Hack E: C-reactive protein as a cardiovascular risk factor-more than an epiphenomenon? Circulation 1999; 100: 96-102.
26. Rink L, Cakman I, Kirchner H : Altered cytokine production in the elderly. Mech Ageing Dev 1998; 15: 199-209.
27. Daynes RA, Araneo BA, Erschler WB, Maloney C, Li GZ, Ryu SY: Altered regulation of IL-6 production with normal aging. J Immunol 1993; 150: 5219-5230.
28. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK: A high plasma concentration of TNF-α is associated with dementia in centenarians. J Gerontol 1999; 54A: M357-M364.
29. Mckay LI, Cidlowski JA: Molecular control of immune/inflammatory responses: Interaction between nuclear factor -kB and steroid receptor-signaling pathways. Endocrine Review 1999; 20: 435-459.
30. Poynter ME, Daynes RA: Peroxisome proliferator-activated receptor a activation modulates cellular redox status, represses nuclear factor-kB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem. 1998; 273: 32833-32841.
31. Vamecq J, Latruffe N: Medical significance of peroxisome proliferator-activated receptors. Lancet 1999; 354: 141-148.
32. Gelman L, Fruchart JC, Auwerx J: An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs.) and their roles in inflammation and cancer. Cell Mol Life Sci. 1999; 55: 932-943.
33. Ricote M, Li AC, Wilson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 1998; 391: 79-82.
34. Jiang C, Ting A, Seed B: PPAR-γ inhibit production of monocyte inflammatory cytokines Nature 1998; 391: 82-89.
35. Fruchart JC, Duries P, Staels B: Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol. 1999; 10: 245-257.
36. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP et al: Activation of human aortic smooth muscle cells is inhibited by PPAR α but not by PPAR γ activators. Nature 1998; 393: 790-793.